Arcadia Biosciences (RKDA) Expected to Announce Earnings on Thursday

by · The Cerbat Gem

Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) is projected to post its Q1 2026 results before the market opens on Thursday, May 7th. Analysts expect Arcadia Biosciences to post earnings of ($0.80) per share and revenue of $1.60 million for the quarter. Individuals can check the company’s upcoming Q1 2026 earning summary page for the latest details on the call scheduled for Thursday, May 14, 2026 at 2:00 PM ET.

Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) last announced its quarterly earnings results on Thursday, March 26th. The basic materials company reported ($0.98) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.66) by ($0.32). The firm had revenue of $0.90 million during the quarter, compared to analysts’ expectations of $1.40 million. Arcadia Biosciences had a negative net margin of 48.15% and a positive return on equity of 37.36%.

Arcadia Biosciences Stock Performance

Shares of NASDAQ RKDA opened at $1.20 on Tuesday. The firm has a market capitalization of $2.47 million, a price-to-earnings ratio of -0.70 and a beta of 0.53. The stock has a 50 day moving average price of $1.54 and a 200 day moving average price of $2.53. Arcadia Biosciences has a 52-week low of $0.89 and a 52-week high of $6.71.

Analysts Set New Price Targets

Separately, Weiss Ratings lowered Arcadia Biosciences from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, April 22nd. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has an average rating of “Sell”.

Check Out Our Latest Research Report on RKDA

Arcadia Biosciences Company Profile

(Get Free Report)

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.

Read More